PortfoliosLab logo

Arcutis Biotherapeutics, Inc. (ARQT)

Equity · Currency in USD · Last updated Mar 26, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Arcutis Biotherapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,693 for a total return of roughly -53.07%. All prices are adjusted for splits and dividends.

ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ARQT

Arcutis Biotherapeutics, Inc.


Arcutis Biotherapeutics, Inc. had a return of -30.88% year-to-date (YTD) and -41.81% in the last 12 months. Over the past 10 years, Arcutis Biotherapeutics, Inc. had an annualized return of -21.39%, while the S&P 500 had an annualized return of 6.84%, indicating that Arcutis Biotherapeutics, Inc. did not perform as well as the benchmark.

1 month-36.77%-0.66%
6 months-44.58%5.67%
1 year-41.81%-10.89%
5 years (annualized)-21.39%6.84%
10 years (annualized)-21.39%6.84%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arcutis Biotherapeutics, Inc. Sharpe ratio is -0.67. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Arcutis Biotherapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Arcutis Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arcutis Biotherapeutics, Inc. is 72.34%, recorded on Mar 24, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-72.34%Feb 9, 2021535Mar 24, 2023
-51.71%Mar 24, 2020155Oct 30, 202067Feb 8, 2021222
-39.4%Mar 11, 20206Mar 18, 20202Mar 20, 20208
-6.89%Feb 27, 20202Feb 28, 20207Mar 10, 20209
-4.64%Feb 25, 20201Feb 25, 20201Feb 26, 20202
-3.77%Feb 11, 20205Feb 18, 20201Feb 19, 20206
-3.51%Feb 5, 20202Feb 6, 20201Feb 7, 20203

Volatility Chart

Current Arcutis Biotherapeutics, Inc. volatility is 50.56%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)